Crowdonomics
This isn’t Alzamend Neuro, Inc.’s most recent raise. Reg A+ · Equity · Nov 2019 (Withdrawn) is more current.View latest round
Alzamend Neuro, Inc.

Reg A+ · Equity · Dec 2016

ClosedReg A+Equity
via the platform · last checked Sep 24, 2026
Raised
$0 / $50M max
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Amendments to this offering

1 amendment
  1. Nov 30, 2016
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Price / share$2.00
Price / share today$8.00
Shares offered25,000,000

$2.00 as sold; $8.00 after the May 2018 split (1:4) (Form 1-K, p. 1).

Offering details

Target—
Max$50,000,000
Min investment—
OpenedDec 8, 2016
Deadline—
ClosedDec 8, 2019
Days active1,095

Links & provenance

Source: SEC EDGAR
0001615774-16-008242
Last synced Sep 24, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.